目的:本研究旨在报告近期发作的症状性甲状腺眼病(TED)患者甲状腺刺激免疫球蛋白(TSI)与临床和放射学参数之间的相关性。
方法:2014年1月至2022年5月在香港中文大学管理的TED患者的前瞻性队列研究。用功能测定法测定血清TSI水平。结果包括临床活动评分(CAS),边缘反射距离1(MR1),眼外肌运动受限(EOMy),眼球突出,和复视。放射学评估包括STIR序列MRI上眼外肌的横截面面积和信号。
结果:总共255名(197名女性)初治患者,平均发病年龄为50±14岁,包括在内。在223例(88%)患者中观察到治疗前TSI水平升高。TSI与CAS呈微弱正相关(r=0.28,P=0.000031),MRD1(r=0.17,P=0.0080),上睑提肌/上直肌复合体的大小(r=0.25,P=0.018)。TSI和STIR信号之间无显著相关性。临床活跃TED的AUC和最佳临界值分别为0.67(95%置信区间:0.60-0.75)和284%(特异性:50%,灵敏度:85%)。64例患者在研究间隔期间接受静脉注射甲基强的松龙(IVMP),他们的基线TSI水平高于没有IVMP的患者(P=0.000044).与基线水平相比,62例患者的连续IVMP后TSI显着降低(P<0.001)。基线和IVMP后TSI水平,对第1个疗程的IVMP有应答和无应答的患者的TSI变化百分比相当.
结论:TSI可以作为诊断的血清生物标志物,预后,和TED的治疗反应。应进一步保证进一步的验证。
UNASSIGNED: This study aims to report correlations between thyroid-stimulating immunoglobulin (TSI) and both clinical and radiological parameters in recent-onset symptomatic thyroid eye disease (TED) patients.
UNASSIGNED: A prospective cohort study of TED patients managed at the Chinese University of Hong Kong from January 2014 to May 2022. Serum TSI levels were determined with the functional assay. Outcomes included the Clinical Activity Score (CAS), marginal reflex distance1 (MRD1), extraocular muscle motility restriction (EOMy),
exophthalmos, and diplopia. The radiological assessment included cross-sectional areas and signal of extraocular muscles on STIR-sequence MRI.
UNASSIGNED: A total of 255 (197 female) treatment-naive patients, with an average onset age of 50 ± 14 years (mean ± s.d.), were included. Elevated pre-treatment TSI level was observed in 223 (88%) patients. There was a weak positive correlation between TSI and CAS (r = 0.28, P = 0.000031), MRD1 (r = 0.17, P = 0.0080), and the size of the levator palpebrae superioris/superior rectus complex (r = 0.25, P = 0.018). No significant correlation existed between TSI and STIR signals. The AUC and optimal cut-off value for clinical active TED were 0.67 (95% CI: 0.60-0.75) and 284% (specificity: 50%, sensitivity: 85%). In total, 64 patients received intravenous methylprednisolone (IVMP) during the study interval, and they had a higher baseline TSI level than those who did not have IVMP (P = 0.000044). Serial post-IVMP TSI among the 62 patients showed a significant reduction compared to the baseline level (P < 0.001). Both the baseline and post-IVMP TSI levels, and percentages of TSI changes were comparable between patients who responded and did not respond to the first course of IVMP.
UNASSIGNED: TSI can be a serum biomarker for the diagnosis, prognosis, and treatment response of TED. Further validation should be warranted.